Valuation: Fresenius SE & Co. KGaA

Capitalization 2.23TCr 2.59TCr 2.05TCr 1.93TCr 3.56TCr 2,50700Cr 3.65TCr 24TCr 9.49TCr 1,18000Cr 9.72TCr 9.51TCr 4,12100Cr P/E ratio 2026 *
11.8x
P/E ratio 2027 * 10.7x
Enterprise value 3.27TCr 3.79TCr 2.99TCr 2.83TCr 5.22TCr 3,66800Cr 5.35TCr 36TCr 14TCr 1,72700Cr 14TCr 14TCr 6,03000Cr EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.29x
Free-Float
72.99%
Yield 2026 *
2.87%
Yield 2027 * 3.12%
1 day+1.12%
1 week+0.33%
Current month-3.88%
1 month-11.14%
3 months-23.87%
6 months-15.08%
Current year-19.05%
1 week 38.3
Extreme 38.3
39.74
1 month 38.16
Extreme 38.16
44.3
Current year 38.16
Extreme 38.16
52.96
1 year 38.16
Extreme 38.16
52.96
3 years 23.93
Extreme 23.93
52.96
5 years 19.69
Extreme 19.69
52.96
10 years 19.69
Extreme 19.69
80.07
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2022
Director of Finance/CFO 46 01/09/2022
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 20/05/2015
Director/Board Member 65 13/05/2016
Director/Board Member 52 01/01/2016
Change 5d. change 1-year change 3-years change Capi.($)
+1.12%+0.33%-8.47%+44.23% 2.57TCr
-1.89%-1.02%+50.02%+35.75% 12TCr
-4.28%-5.82%+4.60%+43.27% 9.38TCr
+0.29%+0.11%+6.89%+44.79% 2.1TCr
-0.74%-1.42%+1.56%+17.00% 2.1TCr
-2.09%-4.10%-20.81%-24.21% 2.05TCr
-0.55%-2.29%+14.42%+162.62% 1.66TCr
-1.93%-5.23%-6.24%+17.99% 1.52TCr
-2.46%-2.96%+34.25%+93.97% 1.28TCr
+0.58%+1.81%-25.78%-11.31% 1.19TCr
Average -1.20%-1.66%+5.04%+42.41% 3.61TCr
Weighted average by Cap. -1.99%-2.32%+17.63%+39.92%

Financials

2026 *2027 *
Net sales 2.36TCr 2.74TCr 2.16TCr 2.04TCr 3.77TCr 2,65100Cr 3.86TCr 26TCr 10TCr 1,24800Cr 10TCr 10TCr 4,35900Cr 2.48TCr 2.88TCr 2.27TCr 2.15TCr 3.96TCr 2,78800Cr 4.06TCr 27TCr 11TCr 1,31200Cr 11TCr 11TCr 4,58300Cr
Net income 189.62Cr 219.85Cr 173.7Cr 164.14Cr 302.6Cr 21TCr 310.21Cr 2.07TCr 806.14Cr 10TCr 825.02Cr 807.43Cr 35TCr 212.32Cr 246.17Cr 194.49Cr 183.78Cr 338.81Cr 24TCr 347.34Cr 2.32TCr 902.62Cr 11TCr 923.77Cr 904.07Cr 39TCr
Net Debt 1.03TCr 1.2TCr 947.93Cr 895.73Cr 1.65TCr 1,16200Cr 1.69TCr 11TCr 4.4TCr 55TCr 4.5TCr 4.41TCr 1,90900Cr 959.81Cr 1.11TCr 879.23Cr 830.81Cr 1.53TCr 1,07700Cr 1.57TCr 10TCr 4.08TCr 51TCr 4.18TCr 4.09TCr 1,77100Cr
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (37.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.; - other (3.1%).
Employees
1,77,783
Date Price Change Volume
19/26/19 39.65 +1.12% 9,41,770
18/26/18 39.21 +1.06% 12,27,581
15/26/15 38.80 -0.69% 13,88,869
14/26/14 39.07 +1.93% 7,54,885
13/26/13 38.33 -3.01% 16,23,042
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
39.65EUR
Average target price
54.79EUR
Spread / Average Target
+38.19%

Quarterly revenue - Rate of surprise